Table of contents

Poster abstract presentation

• P-9 Epimax-related ocular surface toxicity (EROST): the Glasgow experience (7 May, 2023)

  David Lockington, Carl Mulholland, Elisabeth Macdonald
• P-10 Why is the cornea often much thinner than expected after DMEK? A retrospective review and discussion of the clinical implications (7 May, 2023)

  David Lockington, Alasdair Simpson, Sarah Campbell
• P-11 DMEK in cases with aphakia & aniridia. Three-year experience with the safety net technique (7 May, 2023)

  Alfonso Vasquez-Perez
• P-12 Necrotising blepharoconjunctivitis and keratitis in human monkeypox (7 May, 2023)

  Alfonso Vasquez-Perez, Sarah F Osborne, Kaveh Vahdani
• P-13 Topical insulin eye drops in infective keratitis (7 May, 2023)

  Davide Romano, Stephenie J Tiew, Tariq Mohammad
• P-14 Factors associated with the disparity between manifest refractive cylinder and keratometric astigmatism in keratoconic eyes (7 May, 2023)

  Jesse Panhtagani, Elizabeth Law, Max Davidson, Mohamed Elkadim, Harry Roberts, Philip Buckhurst, James Myerscough
• P-15 Descemet’s membrane endothelial keratoplasty without peripheral iridotomy: outcomes and safety profile (category: Research) (7 May, 2023)

  Liam Price, Radhika Patel, Mukhtar Bizrah, Ali Mearza
• P-16 Refractive outcomes of patients undergoing combined Descemet’s membrane endothelial keratoplasty and phacoemulsification surgery (7 May, 2023)

  Radhika Patel, Liam Price, Ali Mearza, Mukhtar Bizrah
• P-17 An innovative technique for practising peeling of donor descemet’s membrane for descemet’s membrane endothelial keratoplasty (7 May, 2023)

  Shakeel Ahmad, James Myerscough, Muhammad Haseeb, Harry Roberts
• P-18 ‘No Nonsense’ DMEK: Safety and efficacy of postureless DMEK with deferred post-operative review until one week (7 May, 2023)

  Ahmad Shakeel, Harry Roberts, Max Davidson, Francis Saunders, James Myerscough, Mark R Wilkins